Cargando…
Development and validation of a plasma-based melanoma biomarker suitable for clinical use
BACKGROUND: In Australia, more money is spent on skin cancer than any other malignancy. Despite this, the mortality rate of melanoma, the deadliest form, has steadily increased over the past 50 years. Diagnostic imprecision and a lack of complimentary molecular biomarkers are partially responsible f...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886119/ https://www.ncbi.nlm.nih.gov/pubmed/29360813 http://dx.doi.org/10.1038/bjc.2017.477 |